title: 2-Deoxy-D-glucose-induced hypothermia in anesthetized rats: Lack of forebrain contribution and critical involvement of the rostral raphe/parapyramidal regions of the medulla oblongata.
abstract: Systemic or central administration of 2-deoxy-d-glucose (2DG), a competitive inhibitor of glucose utilization, induces hypothermia in awake animals and humans. This response is mediated by the central nervous system, though the neural mechanism involved is largely unknown. In this study, I examined possible involvement of the forebrain, which contains the hypothalamic thermoregulatory center, and the medullary rostral raphe/parapyramidal regions (rRPa/PPy), which mediate hypoxia-induced heat-loss responses, in 2DG-induced hypothermia in urethane-chloralose-anesthetized, neuromuscularly blocked, artificially ventilated rats. The intravenous injection of 2DG (250mgkg(-1)) elicited an increase in tail skin temperature and decreases in body core temperature and the respiratory exchange ratio, though it did not induce any significant change in the metabolic rate. These results indicate that the hypothermic response was caused by an increase in heat loss, but not by a decrease in heat production and that it was accompanied by a decrease in carbohydrate utilization and/or an increase in lipid utilization as energy substrates. Complete surgical transection of the brainstem between the hypothalamus and the midbrain had no effect on the 2DG-induced hypothermic responses, suggesting that the hindbrain, but not the forebrain, was sufficient for the responses. However, pretreatment of the rRPa/PPy with the GABAA receptor blocker bicuculline methiodide, but not with vehicle saline, greatly attenuated the 2DG-induced responses, suggesting that the 2DG-induced hypothermia was mediated, at least in part, by GABAergic neurons in the hindbrain and activation of GABAA receptors on cutaneous sympathetic premotor neurons in the rRPa/PPy.
authors.affiliation: Department of Nutritional Science, National Institute of Health and Nutrition, 1-23-1 Toyama, Shinjuku 162-8636, Japan. Electronic address: osaka@nih.go.jp.
authors.forename: Toshimasa
authors.initials: T
authors.lastname: Osaka
mesh_terms: D018686:Anesthetics, Intravenous / Q000494:pharmacology; D000818:Animals; D002698:Chloralose / Q000494:pharmacology; D003655:Decerebrate State / Q000503:physiopathology; D003847:Deoxyglucose; D018682:GABA Agents / Q000494:pharmacology; D007035:Hypothermia / Q000503:physiopathology*; D008297:Male; D023421:Models, Animal; D019148:Neuromuscular Blockade; D016548:Prosencephalon / Q000187:drug effects / Q000503:physiopathology*; D011903:Raphe Nuclei / Q000187:drug effects / Q000503:physiopathology*; D017208:Rats, Wistar; D011963:Receptors, GABA-A / Q000378:metabolism; D012039:Regional Blood Flow / Q000187:drug effects / Q000502:physiology; D012121:Respiration, Artificial; D013623:Tail / Q000503:physiopathology; D022722:Thermogenesis / Q000187:drug effects; D014520:Urethane / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
chemical_list: D018686:Anesthetics, Intravenous; D018682:GABA Agents; D011963:Receptors, GABA-A; D002698:Chloralose; D014520:Urethane; D005680:gamma-Aminobutyric Acid; D003847:Deoxyglucose
keywords: Decerebration; Energy deficiency; Substrate utilization; Thermoregulation